BACKGROUND: The National Lung Screening Trial (NLST) research team reported reduced lung cancer mortality among current and former smokers with a minimum 30 pack-year history who were screened with spiral computed tomography scans compared with chest x-rays. The objectives of the current study were to examine, at 1-year follow-up: 1) risk perceptions of lung cancer and smoking-related diseases and behavior change determinants, 2) whether changes in risk perceptions differed by baseline screening result; and 3) whether changes in risk perceptions affected smoking behavior. METHODS: A 25-item risk perception questionnaire was administered to a subset of participants at 8 American College of Radiology Imaging Network/NLST sites before initial and 1-year follow-up screens. Items assessed risk perceptions of lung cancer and smoking-related diseases, cognitive and emotional determinants of behavior change, and knowledge of smoking risks. RESULTS: Among 430 NLST participants (mean age, 61.0 years; 55.6% men; 91.9% white), half were current smokers at baseline. Overall, risk perceptions and associated cognitive and emotional determinants of behavior change did not change significantly from prescreen trial enrollment to 1-year follow-up and did not differ significantly by screening test result. Changes in risk perceptions were not associated with changes in smoking status (9.7% of participants quit, and 6.6% relapsed) at 1-year follow-up. CONCLUSIONS: Lung screening did not change participants' risk perceptions of lung cancer or smoking-related disease. A negative screening test, which was the most common screening result, did not appear to decrease risk perceptions nor provide false reassurance to smokers.
BACKGROUND: The National Lung Screening Trial (NLST) research team reported reduced lung cancer mortality among current and former smokers with a minimum 30 pack-year history who were screened with spiral computed tomography scans compared with chest x-rays. The objectives of the current study were to examine, at 1-year follow-up: 1) risk perceptions of lung cancer and smoking-related diseases and behavior change determinants, 2) whether changes in risk perceptions differed by baseline screening result; and 3) whether changes in risk perceptions affected smoking behavior. METHODS: A 25-item risk perception questionnaire was administered to a subset of participants at 8 American College of Radiology Imaging Network/NLST sites before initial and 1-year follow-up screens. Items assessed risk perceptions of lung cancer and smoking-related diseases, cognitive and emotional determinants of behavior change, and knowledge of smoking risks. RESULTS: Among 430 NLST participants (mean age, 61.0 years; 55.6% men; 91.9% white), half were current smokers at baseline. Overall, risk perceptions and associated cognitive and emotional determinants of behavior change did not change significantly from prescreen trial enrollment to 1-year follow-up and did not differ significantly by screening test result. Changes in risk perceptions were not associated with changes in smoking status (9.7% of participants quit, and 6.6% relapsed) at 1-year follow-up. CONCLUSIONS: Lung screening did not change participants' risk perceptions of lung cancer or smoking-related disease. A negative screening test, which was the most common screening result, did not appear to decrease risk perceptions nor provide false reassurance to smokers.
Authors: Cynthia O Townsend; Matthew M Clark; James R Jett; Christi A Patten; Darrell R Schroeder; Liza M Nirelli; Stephen J Swensen; Richard D Hurt Journal: Cancer Date: 2005-05-15 Impact factor: 6.860
Authors: Yolanda I Garces; Ping Yang; Julia Parkinson; Xinghua Zhao; Jason A Wampfler; Jon O Ebbert; Jeff A Sloan Journal: Chest Date: 2004-12 Impact factor: 9.410
Authors: Peter B Bach; Joshua N Mirkin; Thomas K Oliver; Christopher G Azzoli; Donald A Berry; Otis W Brawley; Tim Byers; Graham A Colditz; Michael K Gould; James R Jett; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Amir Qaseem; Frank C Detterbeck Journal: JAMA Date: 2012-06-13 Impact factor: 56.272
Authors: Jamie L Studts; Sameer R Ghate; Jaime L Gill; Christina R Studts; Christopher N Barnes; A Scott LaJoie; Michael A Andrykowski; Renato V LaRocca Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-10 Impact factor: 4.254
Authors: Ellen R Gritz; Michelle Cororve Fingeret; Damon J Vidrine; Amy B Lazev; Netri V Mehta; Gregory P Reece Journal: Cancer Date: 2006-01-01 Impact factor: 6.860
Authors: Elyse R Park; Joanna M Streck; Ilana F Gareen; Jamie S Ostroff; Kelly A Hyland; Nancy A Rigotti; Hannah Pajolek; Mark Nichter Journal: Nicotine Tob Res Date: 2013-09-02 Impact factor: 4.244
Authors: Annette R Kaufman; Amber R Koblitz; Alexander Persoskie; Rebecca A Ferrer; William M P Klein; Laura A Dwyer; Elyse R Park Journal: Nicotine Tob Res Date: 2015-05-10 Impact factor: 4.244
Authors: Xiaohua Wang; Joseph K Leader; Renwei Wang; David Wilson; James Herman; Jian-Min Yuan; Jiantao Pu Journal: Lung Cancer Date: 2017-10-27 Impact factor: 5.705
Authors: Annette R Kaufman; Jenny E Twesten; Jerry Suls; Kevin D McCaul; Jamie S Ostroff; Rebecca A Ferrer; Noel T Brewer; Linda D Cameron; Bonnie Halpern-Felsher; Jennifer L Hay; Elyse R Park; Ellen Peters; David R Strong; Erika A Waters; Neil D Weinstein; Paul D Windschitl; William M P Klein Journal: Nicotine Tob Res Date: 2020-10-29 Impact factor: 4.244
Authors: Jennifer A Lewis; W Jeffrey Petty; Janet A Tooze; David P Miller; Caroline Chiles; Antonius A Miller; Christina Bellinger; Kathryn E Weaver Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-01-22 Impact factor: 4.254
Authors: Annette R Kaufman; Laura A Dwyer; Stephanie R Land; William M P Klein; Elyse R Park Journal: Addict Behav Date: 2018-03-14 Impact factor: 3.913
Authors: P V Asharani; Jue Hua Lau; Vanessa Ai Ling Seet; Fiona Devi; Peizhi Wang; Kumarasan Roystonn; Ying Ying Lee; Laxman Cetty; Wen Lin Teh; Swapna Verma; Yee Ming Mok; Siow Ann Chong; Mythily Subramaniam Journal: Int J Environ Res Public Health Date: 2021-02-07 Impact factor: 3.390